NCT03484039

Brief Summary

The purpose of this study is to incorporate multidimensional self-management programs into the routine care of epilepsy patients. Consenting patients will enroll in one of four interventions that help improve medication adherence, increase seizure awareness and documentation, improve memory and deal with stress and depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
332

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 30, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

June 6, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2020

Completed
Last Updated

December 20, 2024

Status Verified

December 1, 2024

Enrollment Period

1.7 years

First QC Date

March 14, 2018

Last Update Submit

December 16, 2024

Conditions

Keywords

memory problemsstressdepressionadherenceseizure documentation

Outcome Measures

Primary Outcomes (1)

  • Changes in Quality of Life in Epilepsy-10 scores

    This is a well-validated measure of quality of life for epilepsy patients. The unit of measure is a composite score ranging from 0-100 with higher scores indicating better quality of life.

    To be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention)

Study Arms (1)

Epilepsy Patients

EXPERIMENTAL

The group will receive the module (a 1-2 hour course on either medication adherence, seizure documentation, memory improvement or stress management) right after a baseline assessment. A post assessment and delayed post assessment will be conducted after the module is administered.

Behavioral: Medication AdherenceBehavioral: Seizure DocumentationBehavioral: Memory ImprovementBehavioral: Stress Management

Interventions

Some subjects will be enrolled in a medication adherence course.

Epilepsy Patients

Some subjects will be enrolled in a seizure documentation course.

Epilepsy Patients

Some subjects will be enrolled in a memory improvement course.

Epilepsy Patients

Some subjects will be enrolled in a stress management course.

Epilepsy Patients

Eligibility Criteria

Age18 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of epilepsy using established criteria
  • Patient self-identified as own primary caregiver
  • English fluency
  • Ability to provide informed consent
  • Ability to complete the study assessments

You may not qualify if:

  • History of non-epileptic seizures
  • History of cognitive impairments that prevents them from providing informed consent and completing study assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UF Health Jacksonville

Jacksonville, Florida, 32209, United States

Location

MeSH Terms

Conditions

EpilepsyMemory DisordersDepression

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Ramon Edmundo D Bautista, MD

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Patients will be enrolled in one module of own choice. Except for Module 3 Submodule 2, every module will consist of a particular intervention, as well as, its accompanying set of assessments.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2018

First Posted

March 30, 2018

Study Start

June 6, 2018

Primary Completion

February 18, 2020

Study Completion

February 18, 2020

Last Updated

December 20, 2024

Record last verified: 2024-12

Locations